Does AXITINIB Cause Neoplasm progression? 1,315 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,315 reports of Neoplasm progression have been filed in association with AXITINIB (INLYTA). This represents 8.3% of all adverse event reports for AXITINIB.
1,315
Reports of Neoplasm progression with AXITINIB
8.3%
of all AXITINIB reports
354
Deaths
236
Hospitalizations
How Dangerous Is Neoplasm progression From AXITINIB?
Of the 1,315 reports, 354 (26.9%) resulted in death, 236 (17.9%) required hospitalization, and 16 (1.2%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXITINIB. However, 1,315 reports have been filed with the FAERS database.
What Other Side Effects Does AXITINIB Cause?
Death (2,222)
Diarrhoea (2,187)
Fatigue (1,816)
Hypertension (1,146)
Off label use (1,075)
Nausea (955)
Decreased appetite (920)
Dysphonia (871)
Disease progression (768)
Blood pressure increased (756)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
GEMCITABINE (960)
Which AXITINIB Alternatives Have Lower Neoplasm progression Risk?
AXITINIB vs AZACITIDINE
AXITINIB vs AZATHIOPRINE
AXITINIB vs AZD-1222
AXITINIB vs AZELAIC ACID
AXITINIB vs AZELASTINE